Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TMS for Complex Regional Pain Syndrome

NCT: NCT03137472 · RECRUITING

NCT IDNCT03137472
StatusRECRUITING
Start Date2017-04-24
Completion2028-06-29
SponsorStanford University (OTHER)
First posted
Last updated

Brief Summary

The aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvement in CRPS-related pain and other associated symptomology (i.e., cognitive, emotional and physical) compared to baseline. Participants will be followed until they reach their baseline for two consecutive weeks to assess safety and duration of symptom alleviation.

Frequently Asked Questions

What is TMS for Complex Regional Pain Syndrome?

TMS for Complex Regional Pain Syndrome is a clinical trial registered under NCT03137472. Current status: RECRUITING.

What is the status of NCT03137472?

The current status of NCT03137472 (TMS for Complex Regional Pain Syndrome) is: RECRUITING.

When did TMS for Complex Regional Pain Syndrome start?

TMS for Complex Regional Pain Syndrome started on 2017-04-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.